Regulation of the bone-restricted IFITM-like (Bril) gene transcription by Sp and Gli family members and CpG methylation

Journal of Biological Chemistry

Volumn 288, Issue 19, 2013, Pages 13278-13294

  Kasaai, Bahar ^a   Gaumond, Marie Hélène ^a   Moffatt, Pierre ^a,b  

^a SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CONSERVED PROMOTER ELEMENT; DEMETHYLATION; EPIGENETIC MODIFICATION; GENE TRANSCRIPTIONS; MEMBRANE PROTEINS; OSTEOGENESIS IMPERFECTA; SKELETAL BIOLOGY; TRANS ACTINGS;

ALKYLATION; BIOLOGICAL MEMBRANES; BONE;

TRANSCRIPTION;

CIS ACTING ELEMENT; GENOMIC DNA; LUCIFERASE; MEMBRANE PROTEIN; PROTEIN GLI; PROTEIN SP; SONIC HEDGEHOG PROTEIN; TRANS ACTING FACTOR; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR OSTERIX; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP3; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 354C;

ANIMAL CELL; ARTICLE; BINDING SITE; BONE RESTRICTED IFITM LIKE GENE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; GC RICH SEQUENCE; GENE; GENE LOCATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INHIBITION KINETICS; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN PROTEIN INTERACTION; RAT; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

BRIL; CPG METHYLATION; GENE EXPRESSION; GLI2; IFITM5; OSTEOBLASTS; OSX; SP1; TRANSCRIPTION PROMOTER; TRANSCRIPTION REGULATION;

3T3 CELLS; ANIMALS; BASE SEQUENCE; BONE AND BONES; CELL DIFFERENTIATION; CONSERVED SEQUENCE; CPG ISLANDS; DNA METHYLATION; FEMALE; GENE SILENCING; HEDGEHOG PROTEINS; HEK293 CELLS; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MEMBRANE PROTEINS; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE ANNOTATION; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN BINDING; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION; SP1 TRANSCRIPTION FACTOR; TATA BOX; TRANSCRIPTION, GENETIC; TRANSCRIPTIONAL ACTIVATION;

EID: 84877708457     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.457010     Document Type: Article

References (91)

1. Moffatt, P., Salois, P., Gaumond, M. H., St-Amant, N., Godin, E., and Lanctôt, C. (2002) Engineered viruses to select genes encoding secreted and membrane-bound proteins in mammalian cells. Nucleic Acids Res. 30, 4285-4294
2. Siegrist, F., Ebeling, M., and Certa, U. (2011) The small interferon-induced transmembrane genes and proteins. J. Interferon Cytokine Res. 31, 183-197
3. Hickford, D., Frankenberg, S., Shaw, G., and Renfree, M. B. (2012) Evolution of vertebrate interferon inducible transmembrane proteins. BMC. Genomics 13, 155
4. Sällman Almén, M., Bringeland, N., Fredriksson, R., and Schiöth, H. B. (2012) The dispanins. A novel gene family of ancient origin that contains 14 human members. PLoS One 7, e31961
5. Moffatt, P., Gaumond, M. H., Salois, P., Sellin, K., Bessette, M. C., Godin, E., de Oliveira, P. T., Atkins, G. J., Nanci, A., and Thomas, G. (2008) Bril. A novel bone-specific modulator of mineralization. J. Bone Miner. Res. 23, 1497-1508
6. Brass, A. L., Huang, I. C., Benita, Y., John, S. P., Krishnan, M. N., Feeley, E. M., Ryan, B. J., Weyer, J. L., van der Weyden, L., Fikrig, E., Adams, D. J., Xavier, R. J., Farzan, M., and Elledge, S. J. (2009) The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243-1254
7. Yount, J. S., Moltedo, B., Yang, Y. Y., Charron, G., Moran, T. M., López, C. B., and Hang, H. C. (2010) Palmitoylome profiling reveals S-palmitoylation-dependent antiviral activity of IFITM3. Nat. Chem. Biol. 6, 610-614
8. Jia, R., Pan, Q., Ding, S., Rong, L., Liu, S. L., Geng, Y., Qiao, W., and Liang, C. (2012) The N-terminal region of IFITM3 modulates its antiviral activity through regulating IFITM3 cellular localization. J. Virol. 86, 13697-13707
9. Yount, J. S., Karssemeijer, R. A., and Hang, H. C. (2012) S-Palmitoylation and ubiquitination differentially regulate interferon-induced transmembrane protein 3 (IFITM3)-mediated resistance to influenza virus. J. Biol. Chem. 287, 19631-19641
10. Lewin, A. R., Reid, L. E., McMahon, M., Stark, G. R., and Kerr, I. M. (1991) Molecular analysis of a human interferon-inducible gene family. Eur. J. Biochem. 199, 417-423
11. Bailey, C. C., Huang, I. C., Kam, C., and Farzan, M. (2012) Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog. 8, e1002909
12. Cho, T. J., Lee, K. E., Lee, S. K., Song, S. J., Kim, K. J., Jeon, D., Lee, G., Kim, H. N., Lee, H. R., Eom, H. H., Lee, Z. H., Kim, O. H., Park, W. Y., Park, S. S., Ikegawa, S., Yoo, W. J., Choi, I. H., and Kim, J. W. (2012)Asingle recurrent mutation in the 5′-UTR of IFITM5 causes osteogenesis imperfecta type V. Am. J. Hum. Genet. 91, 343-348
13. Hanagata, N., Takemura, T., Monkawa, A., Ikoma, T., and Tanaka, J. (2007) Phenotype and gene expression pattern of osteoblast-like cells cultured on polystyrene and hydroxyapatite with pre-adsorbed type-I collagen. J. Biomed. Mater. Res. A 83, 362-371
14. Rigden, D. J., Woodhead, D. D., Wong, P. W., and Galperin, M. Y. (2011) New structural and functional contexts of the Dx[DN]xDG linear motif. Insights into evolution of calcium-binding proteins. PLoS One 6, e21507
15. Hanagata, N., and Li, X. (2011) Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes. Biochem. Biophys. Res. Commun. 409, 378-384
16. Hanagata, N., Li, X., Morita, H., Takemura, T., Li, J., and Minowa, T. (2011) Characterization of the osteoblast-specific transmembrane protein IFITM5 and analysis of IFITM5-deficient mice. J. Bone Miner. Metab. 29, 279-290
17. Lange, U. C., Adams, D. J., Lee, C., Barton, S., Schneider, R., Bradley, A., and Surani, M. A. (2008) Normal germ line establishment in mice carrying a deletion of the Ifitm/Fragilis gene family cluster. Mol. Cell Biol. 28, 4688-4696
18. Feeley, E. M., Sims, J. S., John, S. P., Chin, C. R., Pertel, T., Chen, L. M., Gaiha, G. D., Ryan, B. J., Donis, R. O., Elledge, S. J., and Brass, A. L. (2011) IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog. 7, e1002337
19. Huang, I. C., Bailey, C. C., Weyer, J. L., Radoshitzky, S. R., Becker, M. M., Chiang, J. J., Brass, A. L., Ahmed, A. A., Chi, X., Dong, L., Longobardi, L. E., Boltz, D., Kuhn, J. H., Elledge, S. J., Bavari, S., Denison, M. R., Choe, H., and Farzan, M. (2011) Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 7, e1001258
20. Jiang, D., Weidner, J. M., Qing, M., Pan, X. B., Guo, H., Xu, C., Zhang, X., Birk, A., Chang, J., Shi, P. Y., Block, T. M., and Guo, J. T. (2010) Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J. Virol. 84, 8332-8341
21. Lu, J., Pan, Q., Rong, L., He, W., Liu, S. L., and Liang, C. (2011) The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126-2137
22. Raychoudhuri, A., Shrivastava, S., Steele, R., Kim, H., Ray, R., and Ray, R. B. (2011) ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J. Virol. 85, 12881-12889
23. Weidner, J. M., Jiang, D., Pan, X. B., Chang, J., Block, T. M., and Guo, J. T. (2010) Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms. J. Virol. 84, 12646-12657
24. Hojo, H., Ohba, S., Yano, F., Saito, T., Ikeda, T., Nakajima, K., Komiyama, Y., Nakagata, N., Suzuki, K., Takato, T., Kawaguchi, H., and Chung, U. I. (2012) Gli1 protein participates in hedgehog-mediated specification of osteoblast lineage during endochondral ossification. J. Biol. Chem. 287, 17860-17869
25. Semler, O., Garbes, L., Keupp, K., Swan, D., Zimmermann, K., Becker, J., Iden, S., Wirth, B., Eysel, P., Koerber, F., Schoenau, E., Bohlander, S. K., Wollnik, B., and Netzer, C. (2012) A mutation in the 5′-UTR of IFITM5 creates an in-frame start codon and causes autosomal-dominant osteogenesis imperfecta type V with hyperplastic callus. Am. J. Hum. Genet. 91, 349-357
26. Glorieux, F. H., Rauch, F., Plotkin, H., Ward, L., Travers, R., Roughley, P., Lalic, L., Glorieux, D. F., Fassier, F., and Bishop, N. J. (2000) Type V osteogenesis imperfecta. A new form of brittle bone disease. J. Bone Miner. Res. 15, 1650-1658
27. Rauch, F., Moffatt, P., Cheung, M., Roughley, P., Lalic, L., Lund, A. M., Ramirez, N., Fahiminiya, S., Majewski, J., and Glorieux, F. H. (2013) Osteogenesis imperfecta type V. Marked phenotypic variability despite the presence of the IFITM5 c.-14C3T mutation in all patients. J Med. Genet. 50, 21-24
28. Schmittgen, T. D., and Livak, K. J. (2008) Analyzing real-time PCR data by the comparative CT method. Nat. Protoc. 3, 1101-1108
29. Moffatt, P., Salois, P., St-Amant, N., Gaumond, M. H., and Lanctôt, C. (2004) Identification of a conserved cluster of skin-specific genes encoding secreted proteins. Gene 334, 123-131
30. Müller, M. M., Schreiber, E., Schaffner, W., and Matthias, P. (1989) Rapid test for in vivo stability and DNA binding of mutated octamer binding proteins with "mini-extracts" prepared from transfected cells. Nucleic Acids Res. 17, 6420
31. Faraonio, R., Moffatt, P., Larochelle, O., Schipper, H. M., S-Arnaud, R., and Séguin, C. (2000) Characterization of cis-acting elements in the promoter of the mouse metallothionein-3 gene. Activation of gene expression during neuronal differentiation of P19 embryonal carcinoma cells. Eur. J. Biochem. 267, 1743-1753
32. Larochelle, O., Stewart, G., Moffatt, P., Tremblay, V., and Séguin, C. (2001) Characterization of the mouse metal-regulatory-element- binding proteins, metal element protein-1 and metal regulatory transcription factor-1. Biochem. J 353, 591-601
33. Miao, D., Liu, H., Plut, P., Niu, M., Huo, R., Goltzman, D., and Henderson, J. E. (2004) Impaired endochondral bone development and osteopenia in Gli2-deficient mice. Exp. Cell Res. 294, 210-222
34. Mo, R., Freer, A. M., Zinyk, D. L., Crackower, M. A., Michaud, J., Heng, H. H., Chik, K. W., Shi, X. M., Tsui, L. C., Cheng, S. H., Joyner, A. L., and Hui, C. (1997) Specific and redundant functions of Gli2 and Gli3 zinc finger genes in skeletal patterning and development. Development 124, 113-123
35. Li, L. C., and Dahiya, R. (2002) Meth Primer: designing primers for methylation PCRs. Bioinformatics 18, 1427-1431
36. Kinzler, K. W., and Vogelstein, B. (1990) The GLI gene encodes a nuclear protein which binds specific sequences in the human genome. Mol. Cell Biol. 10, 634-642
37. Winklmayr, M., Schmid, C., Laner-Plamberger, S., Kaser, A., Aberger, F., Eichberger, T., and Frischauf, A. M. (2010) Non-consensus GLI binding sites in hedgehog target gene regulation. BMC Mol. Biol. 11, 2
38. Smale, S. T., and Kadonaga, J. T. (2003) The RNA polymerase II core promoter. Annu. Rev. Biochem. 72, 449-479
39. Bucher, P. (1990) Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212, 563-578
40. Letovsky, J., and Dynan, W. S. (1989) Measurement of the binding of transcription factor Sp1 to a single GC box recognition sequence. Nucleic Acids Res. 17, 2639-2653
41. Sapetschnig, A., Koch, F., Rischitor, G., Mennenga, T., and Suske, G. (2004) Complexity of translationally controlled transcription factor Sp3 isoform expression. J. Biol. Chem. 279, 42095-42105
42. Hagen, G., Müller, S., Beato, M., and Suske, G. (1994) Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J. 13, 3843-3851
43. Kennett, S. B., Udvadia, A. J., and Horowitz, J. M. (1997) Sp3 encodes multiple proteins that differ in their capacity to stimulate or repress transcription. Nucleic Acids Res. 25, 3110-3117
44. Li, L., He, S., Sun, J. M., and Davie, J. R. (2004) Gene regulation by Sp1 and Sp3. Biochem. Cell Biol. 82, 460-471
45. Wierstra, I. (2008) Sp1. Emerging roles. Beyond constitutive activation of TATA-less housekeeping genes. Biochem. Biophys. Res. Commun. 372, 1-13
46. Goto, T., Matsui, Y., Fernandes, R. J., Hanson, D. A., Kubo, T., Yukata, K., Michigami, T., Komori, T., Fujita, T., Yang, L., Eyre, D. R., and Yasui, N. (2006) Sp1 family of transcription factors regulates the human alpha2 (XI) collagen gene (COL11A2) in Saos-2 osteoblastic cells. J Bone Miner. Res. 21, 661-673
47. Le Mée, S., Fromigué, O., and Marie, P. J. (2005) Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp. Cell Res. 302, 129-142
48. Liu, J., Yang, H., Liu, W., Cao, X., and Feng, X. (2005) Sp1 and Sp3 regulate the basal transcription of receptor activator of nuclear factor κB ligand gene in osteoblasts and bone marrow stromal cells. J. Cell Biochem. 96, 716-727
49. Stains, J. P., Lecanda, F., Screen, J., Towler, D. A., and Civitelli, R. (2003) Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters. J. Biol. Chem. 278, 24377-24387
50. Yusa, N., Watanabe, K., Yoshida, S., Shirafuji, N., Shimomura, S., Tani, K., Asano, S., and Sato, N. (2000) Transcription factor Sp3 activates the liver/bone/kidney-type alkaline phosphatase promoter in hematopoietic cells. J. Leukoc. Biol. 68, 772-777
51. Zhang, Y., Hassan, M. Q., Xie, R. L., Hawse, J. R., Spelsberg, T. C., Montecino, M., Stein, J. L., Lian, J. B., van Wijnen, A. J., and Stein, G. S. (2009) Co-stimulation of the bone-related Runx2 P1 promoter in mesenchymal cells by SP1 and ETS transcription factors at polymorphic purine-rich DNA sequences (Y-repeats). J. Biol. Chem. 284, 3125-3135
52. Bouwman, P., Göllner, H., Elsässer, H. P., Eckhoff, G., Karis, A., Grosveld, F., Philipsen, S., and Suske, G. (2000) Transcription factor Sp3 is essential for post-natal survival and late tooth development. EMBO J. 19, 655-661
53. Göllner, H., Dani, C., Phillips, B., Philipsen, S., and Suske, G. (2001) Impaired ossification in mice lacking the transcription factor Sp3. Mech. Dev. 106, 77-83
54. Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., and de Crombrugghe, B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108, 17-29
55. Ducy, P., Zhang, R., Geoffroy, V., Ridall, A. L., and Karsenty, G. (1997) Osf2/Cbfa1. A transcriptional activator of osteoblast differentiation. Cell 89, 747-754
56. Sinha, K. M., and Zhou, X. (2013) Genetic and molecular control of Osterix in skeletal formation. J. Cell Biochem. 114, 975-984
57. Niger, C., Lima, F., Yoo, D. J., Gupta, R. R., Buo, A. M., Hebert, C., and Stains, J. P. (2011) The transcriptional activity of osterix requires the recruitment of Sp1 to the osteocalcin proximal promoter. Bone 49, 683-692
58. Koga, T., Matsui, Y., Asagiri, M., Kodama, T., de Crombrugghe, B., Nakashima, K., and Takayanagi, H. (2005) NFAT and Osterix cooperatively regulate bone formation. Nat. Med. 11, 880-885
59. Sinha, K. M., Yasuda, H., Coombes, M. M., Dent, S. Y., and de Crombrugghe, B. (2010) Regulation of the osteoblast-specific transcription factor Osterix by NO66, a Jumonji family histone demethylase. EMBO J. 29, 68-79
60. Nishimura, R., Wakabayashi, M., Hata, K., Matsubara, T., Honma, S., Wakisaka, S., Kiyonari, H., Shioi, G., Yamaguchi, A., Tsumaki, N., Akiyama, H., and Yoneda, T. (2012) Osterix regulates calcification and degradation of chondrogenic matrices through matrix metalloproteinase 13 (MMP13) expression in association with transcription factor Runx2 during endochondral ossification. J. Biol. Chem. 287, 33179-33190
61. Jheon, A., Bansal, A. K., Zhu, B., Ganss, B., Cheifetz, S., and Sodek, J. (2009) Characterisation of the constitutive over-expression of AJ18 in a novel rat stromal bone marrow cell line (D8-SBMC). Arch. Oral Biol. 54, 705-716
62. Jheon, A. H., Ganss, B., Cheifetz, S., and Sodek, J. (2001) Characterization of a novel KRAB/C2H2 zinc finger transcription factor involved in bone development. J. Biol. Chem. 276, 18282-18289
63. Urrutia, R. (2003) KRAB-containing zinc-finger repressor proteins. Genome Biol. 4, 231
64. Witzgall, R., O'Leary, E., Leaf, A., Onaldi, D., and Bonventre, J. V. (1994) The Kruppel-associated box-A (KRAB-A) domain of zinc finger proteins mediates transcriptional repression. Proc. Natl. Acad. Sci. U.S.A. 91, 4514-4518
65. Gao, L., Sun, C., Qiu, H. L., Liu, H., Shao, H. J., Wang, J., and Li, W. X. (2004) Cloning and characterization of a novel human zinc finger gene, hKid3, from a C2H2-ZNF enriched human embryonic cDNA library. Biochem. Biophys. Res. Commun. 325, 1145-1152
66. Deaton, A. M., and Bird, A. (2011) CpG islands and the regulation of transcription. Genes Dev. 25, 1010-1022
67. Aoyama, T., Okamoto, T., Nagayama, S., Nishijo, K., Ishibe, T., Yasura, K., Nakayama, T., Nakamura, T., and Toguchida, J. (2004) Methylation in the core-promoter region of the chondromodulin-I gene determines the cellspecific expression by regulating the binding of transcriptional activator Sp3. J. Biol. Chem. 279, 28789-28797
68. Zelko, I. N., Mueller, M. R., and Folz, R. J. (2010) CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic. Biol. Med. 48, 895-904
69. Zhu, W. G., Srinivasan, K., Dai, Z., Duan, W., Druhan, L. J., Ding, H., Yee, L., Villalona-Calero, M. A., Plass, C., and Otterson, G. A. (2003) Methylation of adjacent CpG sites affects Sp1/Sp3 binding and activity in the p21Cip1 promoter. Mol. Cell Biol. 23, 4056-4065
70. Thaler, R., Spitzer, S., Karlic, H., Klaushofer, K., and Varga, F. (2012) DMSO is a strong inducer of DNA hydroxymethylation in pre-osteoblastic MC3T3-E1 cells. Epigenetics 7, 635-651
71. Stephens, A. S., Stephens, S. R., Hobbs, C., Hutmacher, D. W., Bacic-Welsh, D., Woodruff, M. A., and Morrison, N. A. (2011) Myocyte enhancer factor 2c, an osteoblast transcription factor identified by dimethyl sulfoxide (DMSO)-enhanced mineralization. J. Biol. Chem. 286, 30071-30086
72. Lee, J. Y., Lee, Y. M., Kim, M. J., Choi, J. Y., Park, E. K., Kim, S. Y., Lee, S. P., Yang, J. S., and Kim, D. S. (2006) Methylation of the mouse DIx5 and Osx gene promoters regulates cell type-specific gene expression. Mol. Cells 22, 182-188
73. Delgado-Calle, J., Sañudo, C., Sánchez-Verde, L., García-Renedo, R. J., Arozamena, J., and Riancho, J. A. (2011) Epigenetic regulation of alkaline phosphatase in human cells of the osteoblastic lineage. Bone 49, 830-838
74. Delgado-Calle, J., Sañudo, C., Bolado, A., Fernández, A. F., Arozamena, J., Pascual-Carra, M. A., Rodriguez-Rey, J. C., Fraga, M. F., Bonewald, L., and Riancho, J. A. (2012) DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J. Bone Miner. Res 27, 926-937
75. Hupkes, M., van Someren, E. P., Middelkamp, S. H., Piek, E., van Zoelen, E. J., and Dechering, K. J. (2011) DNA methylation restricts spontaneous multi-lineage differentiation of mesenchymal progenitor cells, but is stable during growth factor-induced terminal differentiation. Biochim. Bio-phys. Acta 1813, 839-849
76. Long, F., and Ornitz, D. M. (2013) Development of the endochondral skeleton. Cold Spring Harb. Perspect. Biol. 5
77. Robbins, D. J., Fei, D. L., and Riobo, N. A. (2012) The hedgehog signal transduction network. Sci. Signal. 5, re6
78. Zhao, M., Qiao, M., Harris, S. E., Chen, D., Oyajobi, B. O., and Mundy, G. R. (2006) The zinc finger transcription factor Gli2 mediates bone morphogenetic protein 2 expression in osteoblasts in response to hedgehog signaling. Mol. Cell Biol. 26, 6197-6208
79. Sinha, S., and Chen, J. K. (2006) Purmorphamine activates the hedgehog pathway by targeting Smoothened. Nat. Chem. Biol. 2, 29-30
80. Wu, X., Ding, S., Ding, Q., Gray, N. S., and Schultz, P. G. (2002) A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am. Chem. Soc. 124, 14520-14521
81. Wu, X., Walker, J., Zhang, J., Ding, S., and Schultz, P. G. (2004) Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem. Biol. 11, 1229-1238
82. Chung, U. I., Schipani, E., McMahon, A. P., and Kronenberg, H. M. (2001) Indian hedgehog couples chondrogenesis to osteogenesis in endochondral bone development. J. Clin. Invest. 107, 295-304
83. Long, F., Chung, U. I., Ohba, S., McMahon, J., Kronenberg, H. M., and McMahon, A. P. (2004) Ihh signaling is directly required for the osteoblast lineage in the endochondral skeleton. Development 131, 1309-1318
84. Maeda, Y., Nakamura, E., Nguyen, M. T., Suva, L. J., Swain, F. L., Razzaque, M. S., Mackem, S., and Lanske, B. (2007) Indian hedgehog produced by postnatal chondrocytes is essential for maintaining a growth plate and trabecular bone. Proc. Natl. Acad. Sci. U.S.A. 104, 6382-6387
85. St-Jacques, B., Hammerschmidt, M., and McMahon, A. P. (1999) Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. Genes Dev. 13, 2072-2086
86. Tian, Y., Xu, Y., Fu, Q., and Dong, Y. (2012) Osterix is required for sonic hedgehog-induced osteoblastic MC3T3-E1 cell differentiation. Cell Biochem. Biophys. 64, 169-176
87. Shimoyama, A., Wada, M., Ikeda, F., Hata, K., Matsubara, T., Nifuji, A., Noda, M., Amano, K., Yamaguchi, A., Nishimura, R., and Yoneda, T. (2007) Ihh/Gli2 signaling promotes osteoblast differentiation by regulating Runx2 expression and function. Mol. Biol. Cell 18, 2411-2418
88. Koziel, L., Wuelling, M., Schneider, S., and Vortkamp, A. (2005) Gli3 acts as a repressor downstream of Ihh in regulating two distinct steps of chondrocyte differentiation. Development 132, 5249-5260
89. Kesper, D. A., Didt-Koziel, L., and Vortkamp, A. (2010) Gli2 activator function in preosteoblasts is sufficient to mediate Ihh-dependent osteoblast differentiation, whereas the repressor function of Gli2 is dispensable for endochondral ossification. Dev. Dyn. 239, 1818-1826
90. Ohba, S., Kawaguchi, H., Kugimiya, F., Ogasawara, T., Kawamura, N., Saito, T., Ikeda, T., Fujii, K., Miyajima, T., Kuramochi, A., Miyashita, T., Oda, H., Nakamura, K., Takato, T., and Chung, U. I. (2008) Patched1 haploinsufficiency increases adult bone mass and modulates Gli3 repressor activity. Dev. Cell 14, 689-699
91. Park, H. L., Bai, C., Platt, K. A., Matise, M. P., Beeghly, A., Hui, C. C., Nakashima, M., and Joyner, A. L. (2000) Mouse Gli1 mutants are viable but have defects in SHH signaling in combination with a Gli2 mutation. Development 127, 1593-1605